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A carcinoid tumor arising from a mature




Background: Mature cystic teratomas (MCTs) are common benign tumors occurring in the ovaries. Malignant
transformation of teratomas (TMT) occurs in 1–3 % of all MCTs, usually in postmenopausal women. Squamous cell
carcinoma is the most common tumor type. Primary carcinoid tumors of the ovary are uncommon, representing
only 0.3 % of all carcinoid tumors and less than 0.1 % of all ovarian cancers.
Case presentation: A carcinoid tumor of the trabecular type arising from a MCT is presented in a 25-year-old
woman. TMT was detected incidentally. Histologically, uniform, polygonal cells were arranged in a cord and
trabecular pattern. Immunohistochemical staining showed positivity for neuro-specific enolase, synaptophysin, and
CD56.
Conclusions: This case represents a very rare example of carcinoid tumor occurring in a woman younger than
30 years of age. Our findings suggest that sufficient tumor sampling is necessary to avoid overlooking small lesions,
which, in our case, were not detected on either radiologic or gross examination.
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Background
Malignant transformation of teratoma (TMT) is un-
common condition occurring in 1–3 % of all mature
cystic teratomas (MCTs) [1]. Moreover, TMT tends to
occur in postmenopausal women, especially those
who are 15 years older than conventional MCT [2].
The most common malignant tumor type in MCTs is
squamous cell carcinoma, followed by adenocarcin-
oma and carcinoid tumors. Carcinoid tumors of the
ovary are uncommon, particularly primary carcinoid
tumors, representing only approximately 0.3 % of all
such tumors [3].
Herein, we report a rare case of carcinoid tumor arising
from a MCT in a 25-year-old nulliparous woman.
Case presentation
A 25-year-old woman (gravida 0, para 0) presented with
a 4-year history of an asymptomatic pelvic mass that
had increased in size in the previous few months. The
women had an unremarkable medical and gynecological
history with a regular menstrual cycle.
Ultrasonography confirmed the presence of a hypoe-
choic cystic mass of undetermined origin. Further evalu-
ation was performed, including laboratory tests and
computed tomography (CT). The serum level of CA 125
was found to be elevated (139.0 U/mL), and a CT scan
revealed tumors in both the ovaries. The right ovary
showed a 7.0 × 4.5 cm fat-containing cystic mass with
internal calcification, and the left ovary showed 16.0 ×
14.0 cm fat-containing cystic mass with multiple septa
and internal calcification (Fig. 1a). The radiologic find-
ings suggested that both the ovarian tumors were
mature teratomas, and the patient underwent bilateral
ovarian cystectomy. Macroscopically, the left ovary
revealed a multicystic mass containing viscous sebaceous
material and hairs, measuring 20.0 × 12.0 × 7.5 cm. The
cystic wall also contained adipose and bony tissue. Simi-
larly, the right ovary showed a cystic mass filled with
sebum and hairs, measuring 6.5 × 5.0 × 4.0 cm. Frozen
sections of the left ovarian mass were made. On
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microscopic examination, mature squamous and respira-
tory epithelium, as well as mesenchymal tissue including
the bone, cartilage, smooth muscle, and adipose tissue
were observed. In addition, abundant brain tissue, such
as glial tissue and choroid plexus, were observed.
Through the frozen sections, the left ovarian mass was
diagnosed as MCT, and therefore, no further interven-
tion was performed at the time of the operation.
However, formalin-fixed, paraffin-embedded multiple
sections of the left ovary revealed an incidental
microscopic focus that displayed a monomorphic
population of polygonal cells beneath the respiratory
epithelium. The focus measured 0.5 cm in diameter
and was not observed in the frozen sections. The
tumor cells formed cords and trabeculae and had
scant, eosinophilic cytoplasm, and round nuclei with
mild atypia (Fig. 1b, c). Immunohistochemical staining
showed positivity for neuro-specific enolase (NSE),
synaptophysin, and CD56 (Fig. 1d, e). One mitosis
was seen per 10 high-power fields, and the Ki-67
proliferative index was 1 % (Fig. 1f ). Therefore, the
tumor was classified as low grade. Based on the mor-
phological and immunohistochemical findings, the
tumor was diagnosed as a carcinoid tumor (trabecular
type) arising from a MCT. The right ovary, on the
other hand, had no evidence of somatic type tumors.
The patient received no further treatment. And she had
no clinical symptoms associated with carcinoid syndrome
including cardiac involvement that might be a major cause
of death in this syndrome, so cardiac ultrasound had not
performed. Also, no evidence of recurrence or metastasis
was detected on abdomen and pelvic computer tomog-
raphy (CT) after 8 months of follow-up.
Conclusions
MCTs account for approximately 20 % of all ovarian
neoplasms, and are often diagnosed in young women
[4]. Teratomas consist of diverse tissues derived from
the three germ cell layers, the ectoderm, mesoderm, and
endoderm. MCTs are usually benign; however, in 1–3 %
of cases, they undergo TMT. Furthermore, patients with
TMT are 15 years older than those with MCT without
malignant transformation. The most common tumor
type is squamous cell carcinoma, comprising about 80 %
of cases of TMT. Other tumor types, including adeno-
carcinoma, thyroid carcinoma, and carcinoid tumor,
have also been reported [1, 5].
Primary carcinoid tumors of the ovary are uncommon,
accounting for only 0.3 % of all carcinoid tumors and
less than 0.1 % of all ovarian cancers. Carcinoid tumors
most commonly occur in the gastrointestinal tract. The
second most common organ in which these tumors
Fig. 1 a Gross appearance of the left ovary: A multicystic mass containing viscous sebaceous material and hair is visible. b, c Uniform cells are
arranged in cords and trabeculae beneath the respiratory epithelium. d, e Tumor cells showing positivity for CD56 and synaptophysin. f The Ki-67
proliferative index in the carcinoid tumor is 1 %
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occur is the lungs. Ovarian carcinoid tumors may be pri-
mary or metastatic [3]. Most primary ovarian carcinoid
tumors are unilateral; however, in 16 % of cases, the
contralateral ovary displays a cystic teratoma or a mu-
cinous neoplasm [6].
Primary ovarian carcinoid tumors are classified into
four types, i.e., the insular, trabecular, mucinous, and
mixed types. The most common type is the insular type
[7]. Primary ovarian carcinoid tumors, in particular one
third of the insular type, have been associated with the
carcinoid syndrome despite the absence of metastasis
[4]. The other types of primary ovarian carcinoid tumors
are not usually associated with carcinoid syndrome.
In the present case, the patient had a trabecular type
carcinoid tumor and did not have any symptoms of car-
cinoid syndrome for the previous 4 years.
Preoperative diagnosis of MCT of the ovary can be
made through radiologic findings considering the pres-
ence of the fat tissue, hairs, bone, and cartilage within
the tumor. However, TMT is not easily recognized. In
most cases, a definitive diagnosis is possible only on
postoperative examination of multiple tissue sections.
Similarly, a small carcinoid tumor was identified inci-
dentally in the present case. Tumor cells revealed immu-
noreactivity for the neuroendocrine markers following
NSE, synaptophysin, and CD56, and these findings are
typical of carcinoid tumors. This case suggests that, in
teratomas, sufficient sampling from solid components is
important not to miss the microscopic small areas show-
ing TMT.
The optimal treatment strategy for TMT remains the
main challenge. Surgical excision is regarded as the first
approach [8]. A more aggressive surgical treatment may
be considered according to the age of the patient. TMT
usually occurs in postmenopausal women; therefore,
radical surgery such as hysterectomy and bilateral
salpingo-oophorectomy may be considered in such
cases. However, in younger women, particularly those
that are nulliparous, preservation of fertility is import-
ant. Despite the fact that there is no consensus regarding
the optimal TMT treatment strategy for younger
patients, local excision seems to be the most rational
option [9]. According to the literature, the prognosis of
organ-confined tumors is excellent for primary ovarian
carcinoid tumors and the 10-year survival rates are
approximately 100 %. However, in the advanced state,
the 5-year survival rate decreases to 33 % [10].
In conclusion, a primary carcinoid tumor arising from
a MCT is very rare in young patients, particularly those
less than 30 years old, as demonstrated in the present
case. Moreover, preoperative identification of TMT is
not easy. Therefore, examination of multiple sections is
necessary to detect even the smallest focus showing ma-
lignant transformation within solid tumor components.
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